Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Doktor Dæk ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.6% 2.6%   Bankruptcy risk   8.1% 5.3% 17.4% 8.2% 12.4% 9.1% 17.1% 17.1%   Credit score (0-100)   31 43 9 29 18 26 10 10   Credit rating   BB BBB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   249 113 -15.2 137 -66.3 28.0 0.0 0.0   EBITDA   249 113 -15.2 137 -66.3 28.0 0.0 0.0   EBIT   208 72.3 -56.2 137 -66.3 28.0 0.0 0.0   Pre-tax profit (PTP)   199.3 62.3 -68.9 120.4 -76.2 13.2 0.0 0.0   Net earnings   155.2 48.6 -53.7 93.9 -59.5 12.4 0.0 0.0   Pre-tax profit without non-rec. items   199 62.3 -68.9 120 -76.2 13.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   81.8 40.9 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   238 137 38.1 132 72.5 85.0 35.0 35.0   Interest-bearing liabilities   353 458 480 483 472 467 0.0 0.0   Balance sheet total (assets)   766 685 600 700 583 553 35.0 35.0   Net Debt   277 60.2 -28.6 -137 427 450 -35.0 -35.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   249 113 -15.2 137 -66.3 28.0 0.0 0.0   Gross profit growth   172.9% -54.6% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   766 685 600 700 583 553 35 35   Balance sheet change%   52.6% -10.6% -12.4% 16.7% -16.7% -5.2% -93.7% 0.0%   Added value   249.2 113.2 -15.2 137.4 -66.3 28.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -82 -82 -82 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   83.6% 63.9% 368.7% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   32.8% 10.0% -8.7% 21.1% -10.3% 4.9% 0.0% 0.0%   ROI %   41.2% 12.2% -10.1% 24.3% -11.4% 5.1% 0.0% 0.0%   ROE %   96.6% 25.9% -61.5% 110.4% -58.1% 15.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.1% 20.0% 6.3% 18.9% 12.4% 15.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   111.0% 53.2% 187.9% -100.0% -643.9% 1,606.6% 0.0% 0.0%   Gearing %   148.2% 335.0% 1,259.6% 365.9% 651.0% 549.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.6% 2.5% 2.7% 3.5% 2.1% 3.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.1 1.0 1.1 1.0 1.2 0.0 0.0   Current Ratio   1.3 1.2 1.1 1.2 1.1 1.2 0.0 0.0   Cash and cash equivalent   76.5 398.2 508.4 620.4 45.2 16.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   156.4 95.9 38.1 132.0 72.5 85.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0